-
1
-
-
0032881310
-
Ats/ers/wasog statement on sarcoidosis american thoracic society/european respiratory society/world association of sarcoidosis and other granulomatous disorders
-
Hunninghake GW, Costabel U, Ando M, et al. ATS/ERS/WASOG Statement on sarcoidosis. American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and other Granulomatous Disorders. Sarcoidosis Vasc Diffuse Lung Dis 1999; 16:149-173
-
(1999)
Sarcoidosis Vasc Diffuse Lung Dis
, vol.16
, pp. 149-173
-
-
Hunninghake, G.W.1
Costabel, U.2
Ando, M.3
-
2
-
-
79251525181
-
Sarcoidosis: Clinical presentation, immunopathogenesis, and therapeutics
-
Iannuzzi MC, Fontana Jr. Sarcoidosis: Clinical presentation, immunopathogenesis, and therapeutics. JAMA 2011; 305:391-399
-
(2011)
JAMA
, vol.305
, pp. 391-399
-
-
Iannuzzi, M.C.1
Fontana, J.R.2
-
3
-
-
0035891579
-
Clinical characteristics of patients in a case control study of sarcoidosis
-
Baughman RP, Teirstein AS, Judson MA, et al. Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med 2001; 164:1885-1889
-
(2001)
Am J Respir Crit Care Med
, vol.164
, pp. 1885-1889
-
-
Baughman, R.P.1
Teirstein, A.S.2
Judson, M.A.3
-
6
-
-
36348968294
-
Treatments for pulmonary sarcoidosis
-
Paramothayan S, Lasserson T. Treatments for pulmonary sarcoidosis. Respir Med 2008; 102:1-9
-
(2008)
Respir Med
, vol.102
, pp. 1-9
-
-
Paramothayan, S.1
Lasserson, T.2
-
9
-
-
84878779658
-
Established and experimental medical therapy of pulmonary sarcoidosis
-
Baughman RP, Nunes H, Sweiss NJ, Lower EE. Established and experimental medical therapy of pulmonary sarcoidosis. Eur Respir J 2013; 41:1424-1438
-
(2013)
Eur Respir J
, vol.41
, pp. 1424-1438
-
-
Baughman, R.P.1
Nunes, H.2
Sweiss, N.J.3
Lower, E.E.4
-
10
-
-
33749447564
-
Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement
-
Baughman RP, Drent M, Kavuru M, et al. Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement. Am J Respir Crit Care Med 2006; 174:795-802
-
(2006)
Am J Respir Crit Care Med
, vol.174
, pp. 795-802
-
-
Baughman, R.P.1
Drent, M.2
Kavuru, M.3
-
11
-
-
49649098822
-
Efficacy of infliximab in extrapulmonary sarcoidosis: Results from a randomised trial
-
Judson MA, Baughman RP, Costabel U, et al. Efficacy of infliximab in extrapulmonary sarcoidosis: Results from a randomised trial. Eur Respir J 2008; 31:1189-1196
-
(2008)
Eur Respir J
, vol.31
, pp. 1189-1196
-
-
Judson, M.A.1
Baughman, R.P.2
Costabel, U.3
-
12
-
-
84866541262
-
Cost per responder associated with biologic therapies for Crohn's disease, psoriasis, and rheumatoid arthritis
-
Liu Y, Wu EQ, Bensimon AG, et al. Cost per responder associated with biologic therapies for Crohn's disease, psoriasis, and rheumatoid arthritis. Adv Ther 2012; 29:620-634
-
(2012)
Adv Ther
, vol.29
, pp. 620-634
-
-
Liu, Y.1
Wu, E.Q.2
Bensimon, A.G.3
-
13
-
-
83455244339
-
Therapy for sarcoidosis: Evidence-based recommendations
-
Baughman RP, Nunes H. Therapy for sarcoidosis: Evidence-based recommendations. Expert Rev Clin Immunol 2012; 8:95-103
-
(2012)
Expert Rev Clin Immunol
, vol.8
, pp. 95-103
-
-
Baughman, R.P.1
Nunes, H.2
-
14
-
-
77951623623
-
Pharmacotherapy for pulmonary sarcoidosis: A Delphi consensus study
-
Schutt AC, Bullington WM, Judson MA. Pharmacotherapy for pulmonary sarcoidosis: A Delphi consensus study. Respir Med 2010; 104:717-723
-
(2010)
Respir Med
, vol.104
, pp. 717-723
-
-
Schutt, A.C.1
Bullington, W.M.2
Judson, M.A.3
-
17
-
-
77749277178
-
Methotrexate -how does it really work?
-
Chan ES, Cronstein BN. Methotrexate -how does it really work? Nat Rev Rheumatol 2010; 6:175-178
-
(2010)
Nat Rev Rheumatol
, vol.6
, pp. 175-178
-
-
Chan, E.S.1
Cronstein, B.N.2
-
18
-
-
84875225940
-
Corticosteroid resistance in patients with asthma and chronic obstructive pulmonary disease
-
Barnes PJ. Corticosteroid resistance in patients with asthma and chronic obstructive pulmonary disease. J Allergy Clin Immunol 2013; 131:636-645
-
(2013)
J Allergy Clin Immunol
, vol.131
, pp. 636-645
-
-
Barnes, P.J.1
-
19
-
-
4243430012
-
-
Oxford Centre for Evidence-Based Medicine. March
-
Oxford Centre for Evidence-Based Medicine. Levels of evidence (March 2009). http://www.cebm.net/index.aspxö=1025
-
(2009)
Levels Of Evidence
-
-
-
20
-
-
33744462344
-
Evidence-based clinical guidelines: A new system to better determine true strength of recommendation
-
Roddy E, Zhang W, Doherty M, et al. Evidence-based clinical guidelines: A new system to better determine true strength of recommendation. J Eval Clin Pract 2006; 12:347-352
-
(2006)
J Eval Clin Pract
, vol.12
, pp. 347-352
-
-
Roddy, E.1
Zhang, W.2
Doherty, M.3
-
21
-
-
0034056475
-
Methotrexate is steroid sparing in acute sarcoidosis: Results of a double blind, randomized trial
-
Baughman RP, Winget DB, Lower EE. Methotrexate is steroid sparing in acute sarcoidosis: Results of a double blind, randomized trial. Sarcoidosis Vasc Diffuse Lung Dis 2000; 17:60-66
-
(2000)
Sarcoidosis Vasc Diffuse Lung Dis
, vol.17
, pp. 60-66
-
-
Baughman, R.P.1
Winget, D.B.2
Lower, E.E.3
-
22
-
-
84881669350
-
Methotrexate versus azathioprine in second line therapy of sarcoidosis
-
doi:10.1378/chest.12-1728. [Epub ahead of print]
-
Vorselaars AD, Wuyts WA, Vorselaars VM, et al. Methotrexate versus azathioprine in second line therapy of sarcoidosis. Chest 2013; doi:10.1378/chest.12-1728. [Epub ahead of print]
-
(2013)
Chest
-
-
Vorselaars, A.D.1
Wuyts, W.A.2
Vorselaars, V.M.3
-
24
-
-
0036326803
-
What is the future of methotrexate in sarcoidosis? A study and review
-
Vucinic VM. What is the future of methotrexate in sarcoidosis? A study and review. Curr Opin Pulm Med 2002; 8:470-476
-
(2002)
Curr Opin Pulm Med
, vol.8
, pp. 470-476
-
-
Vucinic, V.M.1
-
26
-
-
0032608383
-
Methotrexate treatment for sarcoidassociated panuveitis
-
Dev S, McCallum RM, Jaffe GJ. Methotrexate treatment for sarcoidassociated panuveitis. Ophthalmology 1999; 106:111-118
-
(1999)
Ophthalmology
, vol.106
, pp. 111-118
-
-
Dev, S.1
McCallum, R.M.2
Jaffe, G.J.3
-
28
-
-
0028904011
-
Prolonged use of methotrexate for sarcoidosis
-
Lower EE, Baughman RP. Prolonged use of methotrexate for sarcoidosis. Arch Intern Med 1995; 155:846-851
-
(1995)
Arch Intern Med
, vol.155
, pp. 846-851
-
-
Lower, E.E.1
Baughman, R.P.2
-
29
-
-
0025663791
-
The effect of corticosteroid or methotrexate therapy on lung lymphocytes and macrophages in sarcoidosis
-
Baughman RP, Lower EE. The effect of corticosteroid or methotrexate therapy on lung lymphocytes and macrophages in sarcoidosis. Am Rev Respir Dis 1990; 142:1268-1271
-
(1990)
Am Rev Respir Dis
, vol.142
, pp. 1268-1271
-
-
Baughman, R.P.1
Lower, E.E.2
-
30
-
-
0025228525
-
The use of low dose methotrexate in refractory sarcoidosis
-
Lower EE, Baughman RP. The use of low dose methotrexate in refractory sarcoidosis. Am J Med Sci 1990; 299:153-157
-
(1990)
Am J Med Sci
, vol.299
, pp. 153-157
-
-
Lower, E.E.1
Baughman, R.P.2
-
31
-
-
0017662142
-
Cutaneous sarcoidosis treated with methotrexate
-
Veien NK, Brodthagen H. Cutaneous sarcoidosis treated with methotrexate. Br J Dermatol 1977; 97:213-216
-
(1977)
Br J Dermatol
, vol.97
, pp. 213-216
-
-
Veien, N.K.1
Brodthagen, H.2
-
32
-
-
84872496003
-
Central skeletal sarcoidosis: A case report with sustained remission only on methotrexate, and a literature review on the imaging approach, treatment, and assessment of disease activity
-
Sakellariou GT, Anastasilakis AD, Karanikolas D, et al. Central skeletal sarcoidosis: A case report with sustained remission only on methotrexate, and a literature review on the imaging approach, treatment, and assessment of disease activity. Mod Rheumatol 2013; 23:175-181
-
(2013)
Mod Rheumatol
, vol.23
, pp. 175-181
-
-
Sakellariou, G.T.1
Anastasilakis, A.D.2
Karanikolas, D.3
-
33
-
-
84881662897
-
A sarcoidosis patient with hand involvement and large pulmonary lymph nodes: Results of 1-year treatment with methotrexate
-
SUPPL.
-
Alemdaroglu E, Erturk A, Eroglu AG. A sarcoidosis patient with hand involvement and large pulmonary lymph nodes: Results of 1-year treatment with methotrexate. Clin Rheumatol 2013; 32 (Suppl.):S71-S73
-
(2013)
Clin Rheumatol
, vol.32
-
-
Alemdaroglu, E.1
Erturk, A.2
Eroglu, A.G.3
-
34
-
-
84865267964
-
Oral involvement in sarcoidosis: Report of 12 cases
-
Bouaziz A, Le Scanff J, Chapelon-Abric C, et al. Oral involvement in sarcoidosis: Report of 12 cases. QJM 2012; 105:755-767
-
(2012)
QJM
, vol.105
, pp. 755-767
-
-
Bouaziz, A.1
Le Scanff, J.2
Chapelon-Abric, C.3
-
35
-
-
84874306256
-
An unusual case of sarcoidosis in an adult patient with sickle cell disease: Management with methotrexate and low dose of steroid
-
Delmonte L, Zamo A, Cantini M, de Franceschi L. An unusual case of sarcoidosis in an adult patient with sickle cell disease: Management with methotrexate and low dose of steroid. Am J Hematol 2012; 88:243
-
(2012)
Am J Hematol
, vol.88
, pp. 243
-
-
Delmonte, L.1
Zamo, A.2
Cantini, M.3
De Franceschi, L.4
-
36
-
-
83255185718
-
Clinical features of spinal cord sarcoidosis: Analysis of 17 neurosarcoidosis patients
-
Sakushima K, Yabe I, Nakano F, et al. Clinical features of spinal cord sarcoidosis: Analysis of 17 neurosarcoidosis patients. J Neurol 2011; 258:2163-2167
-
(2011)
J Neurol
, vol.258
, pp. 2163-2167
-
-
Sakushima, K.1
Yabe, I.2
Nakano, F.3
-
37
-
-
83555163968
-
Rare localizations of bone sarcoidosis; two case reports and review of the literature
-
Bargagli E, Olivieri C, Penza F, et al. Rare localizations of bone sarcoidosis; two case reports and review of the literature. Rheumatol Int 2011; 31:1503-1506
-
(2011)
Rheumatol Int
, vol.31
, pp. 1503-1506
-
-
Bargagli, E.1
Olivieri, C.2
Penza, F.3
-
38
-
-
80052903086
-
Skin as a marker of internal disease: A case of sarcoidosis
-
Gautam M, Patil S, Munde P. Skin as a marker of internal disease: A case of sarcoidosis. Indian J Dermatol 2011; 56:439-441
-
(2011)
Indian J Dermatol
, vol.56
, pp. 439-441
-
-
Gautam, M.1
Patil, S.2
Munde, P.3
-
40
-
-
77953309019
-
Neurosarcoidosis presenting as an isolated intrasellar mass: Case report and review of the literature
-
Kimball MM, Wind JJ, Codispoti KE, et al. Neurosarcoidosis presenting as an isolated intrasellar mass: Case report and review of the literature. Clin Neuropathol 2010; 29:156-162
-
(2010)
Clin Neuropathol
, vol.29
, pp. 156-162
-
-
Kimball, M.M.1
Wind, J.J.2
Codispoti, K.E.3
-
41
-
-
68949122636
-
Sarcoidal anemia and leukopenia treated with methotrexate and mycophenolate mofetil
-
Kalajian AH, Van Meter JR, Callen JP. Sarcoidal anemia and leukopenia treated with methotrexate and mycophenolate mofetil. Arch Dermatol 2009; 145:905-909
-
(2009)
Arch Dermatol
, vol.145
, pp. 905-909
-
-
Kalajian, A.H.1
Van Meter, J.R.2
Callen, J.P.3
-
42
-
-
84866793900
-
Successful treatment of chylous ascites secondary to sarcoidosis with methotrexate
-
Mannam P, Boselli JM, Schulman ES. Successful treatment of chylous ascites secondary to sarcoidosis with methotrexate. Hosp Pract 2009; 37:144-146
-
(2009)
Hosp Pract
, vol.37
, pp. 144-146
-
-
Mannam, P.1
Boselli, J.M.2
Schulman, E.S.3
-
44
-
-
54049113475
-
Heart-shaped lesion secondary to neurosarcoidosis
-
Suarez Zambrano GA, Hutton GJ. Heart-shaped lesion secondary to neurosarcoidosis. Arch Neurol 2008; 65:1388-1389
-
(2008)
Arch Neurol
, vol.65
, pp. 1388-1389
-
-
Suarez Zambrano, G.A.1
Hutton, G.J.2
-
45
-
-
39749156463
-
A rare presentation of sarcoidosis, back pain and spondylolisthesis
-
Morgan SS, Aslam MB, Mukkanna KS, Ampat G. A rare presentation of sarcoidosis, back pain and spondylolisthesis. J Bone Joint Surg Br 2008; 90:240-242
-
(2008)
J Bone Joint Surg Br
, vol.90
, pp. 240-242
-
-
Morgan, S.S.1
Aslam, M.B.2
Mukkanna, K.S.3
Ampat, G.4
-
47
-
-
33745264450
-
Natural history of hepatic sarcoidosis and its response to treatment
-
Kennedy PT, Zakaria N, Modawi SB, et al. Natural history of hepatic sarcoidosis and its response to treatment. Eur J Gastroenterol Hepatol 2006; 18:721-726
-
(2006)
Eur J Gastroenterol Hepatol
, vol.18
, pp. 721-726
-
-
Kennedy, P.T.1
Zakaria, N.2
Modawi, S.B.3
-
48
-
-
15044339461
-
Cutaneous sarcoidosis in Asians: A report of 25 patients from Singapore
-
Chong WS, Tan HH, Tan SH. Cutaneous sarcoidosis in Asians: A report of 25 patients from Singapore. Clin Exp Dermatol 2005; 30:120-124
-
(2005)
Clin Exp Dermatol
, vol.30
, pp. 120-124
-
-
Chong, W.S.1
Tan, H.H.2
Tan, S.H.3
-
49
-
-
22244469767
-
Clinical images: Radiographic healing of osseous sarcoidosis
-
Gardner GC, Hunter JC. Clinical images: Radiographic healing of osseous sarcoidosis. Arthritis Rheum 2005; 52:2225
-
(2005)
Arthritis Rheum
, vol.52
, pp. 2225
-
-
Gardner, G.C.1
Hunter, J.C.2
-
50
-
-
9144263756
-
Sinonasal sarcoidosis: Review and report of fifteen cases
-
Braun JJ, Gentine A, Pauli G. Sinonasal sarcoidosis: Review and report of fifteen cases. Laryngoscope 2004; 114:1960-1963
-
(2004)
Laryngoscope
, vol.114
, pp. 1960-1963
-
-
Braun, J.J.1
Gentine, A.2
Pauli, G.3
-
51
-
-
0037370595
-
Use of methotrexate in sarcoid-associated optic neuropathy
-
Maust HA, Foroozan R, Sergott RC, et al. Use of methotrexate in sarcoid-associated optic neuropathy. Ophthalmology 2003; 110:559-563
-
(2003)
Ophthalmology
, vol.110
, pp. 559-563
-
-
Maust, H.A.1
Foroozan, R.2
Sergott, R.C.3
-
53
-
-
0034917163
-
Symptomatic muscle involvement in neurosarcoidosis: A clinicopathological study of 5 cases
-
Scola RH, Werneck LC, Prevedello DM, et al. Symptomatic muscle involvement in neurosarcoidosis: A clinicopathological study of 5 cases. Arq Neuropsiquiatr 2001; 59:347-352
-
(2001)
Arq Neuropsiquiatr
, vol.59
, pp. 347-352
-
-
Scola, R.H.1
Werneck, L.C.2
Prevedello, D.M.3
-
54
-
-
0033055304
-
Spinal cord granulomatous vasculitis: An unusual clinical presentation of sarcoidosis
-
Diri E, Espinoza CG, Espinoza LR. Spinal cord granulomatous vasculitis: An unusual clinical presentation of sarcoidosis. J Rheumatol 1999; 26:1408-1410
-
(1999)
J Rheumatol
, vol.26
, pp. 1408-1410
-
-
Diri, E.1
Espinoza, C.G.2
Espinoza, L.R.3
-
55
-
-
0342948885
-
Vertebral and rib sarcoidosis; long-Term clinical remission with methotrexate
-
Mana J, Gomez-Vaquero C, Dorca J, Pujol R. Vertebral and rib sarcoidosis; long-Term clinical remission with methotrexate. Clin Rheumatol 1999; 18:492-494
-
(1999)
Clin Rheumatol
, vol.18
, pp. 492-494
-
-
Mana, J.1
Gomez-Vaquero, C.2
Dorca, J.3
Pujol, R.4
-
56
-
-
0030815776
-
Low-dose methotrexate therapy for childhood sarcoidosis
-
Gedalia A, Molina JF, Ellis GS Jr, et al. Low-dose methotrexate therapy for childhood sarcoidosis. J Pediatr 1997; 130:25-29
-
(1997)
J Pediatr
, vol.130
, pp. 25-29
-
-
Gedalia, A.1
Molina, J.F.2
Ellis Jr., G.S.3
-
57
-
-
0029131444
-
Low-dose methotrexate: An effective corticosteroid-sparing agent in the musculoskeletal manifestations of sarcoidosis
-
Kaye O, Palazzo E, Grossin M, et al. Low-dose methotrexate: An effective corticosteroid-sparing agent in the musculoskeletal manifestations of sarcoidosis. Br J Rheumatol 1995; 34:642-644
-
(1995)
Br J Rheumatol
, vol.34
, pp. 642-644
-
-
Kaye, O.1
Palazzo, E.2
Grossin, M.3
-
58
-
-
0028087969
-
Laryngeal and cutaneous sarcoidosis treated with methotrexate
-
Henderson CA, Ilchyshyn A, Curry AR. Laryngeal and cutaneous sarcoidosis treated with methotrexate. J R Soc Med 1994; 87:632-633
-
(1994)
J R Soc Med
, vol.87
, pp. 632-633
-
-
Henderson, C.A.1
Ilchyshyn, A.2
Curry, A.R.3
-
59
-
-
0027959258
-
Weekly low-dose methotrexate therapy for sarcoidosis
-
Suda T, Sato A, Toyoshima M, et al. Weekly low-dose methotrexate therapy for sarcoidosis. Intern Med 1994; 33:437-440
-
(1994)
Intern Med
, vol.33
, pp. 437-440
-
-
Suda, T.1
Sato, A.2
Toyoshima, M.3
-
63
-
-
0014382271
-
Spontaneous remission or response to methotrexate in sarcoidosis
-
Lacher MJ. Spontaneous remission or response to methotrexate in sarcoidosis. Ann Intern Med 1968; 69:1247-1248
-
(1968)
Ann Intern Med
, vol.69
, pp. 1247-1248
-
-
Lacher, M.J.1
-
64
-
-
67549096874
-
Multinational evidence-based recommendations for the use of methotrexate in rheumatic disorders with a focus on rheumatoid arthritis: Integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E Initiative
-
Visser K, Katchamart W, Loza E, et al. Multinational evidence-based recommendations for the use of methotrexate in rheumatic disorders with a focus on rheumatoid arthritis: Integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E Initiative. Ann Rheum Dis 2009; 68:1086-1093
-
(2009)
Ann Rheum Dis
, vol.68
, pp. 1086-1093
-
-
Visser, K.1
Katchamart, W.2
Loza, E.3
-
69
-
-
0024589484
-
Increasing methotrexate effect with increasing dose in the treatment of resistant rheumatoid arthritis
-
Furst DE, Koehnke R, Burmeister LF, et al. Increasing methotrexate effect with increasing dose in the treatment of resistant rheumatoid arthritis. J Rheumatol 1989; 16:313-320
-
(1989)
J Rheumatol
, vol.16
, pp. 313-320
-
-
Furst, D.E.1
Koehnke, R.2
Burmeister, L.F.3
-
70
-
-
0028306446
-
Tolerability of methotrexate starting with 15 or 25 mg/week for rheumatoid arthritis
-
Schnabel A, Reinhold-Keller E, Willmann V, Gross WL. Tolerability of methotrexate starting with 15 or 25 mg/week for rheumatoid arthritis. Rheumatol Int 1994; 14:33-38
-
(1994)
Rheumatol Int
, vol.14
, pp. 33-38
-
-
Schnabel, A.1
Reinhold-Keller, E.2
Willmann, V.3
Gross, W.L.4
-
71
-
-
35648991026
-
Intensive treatment with methotrexate in early rheumatoid arthritis: Aiming for remission. Computer assisted management in early rheumatoid arthritis (camera, an openlabel strategy trial)
-
Verstappen SM, Jacobs JW, van der Veen MJ, et al. Intensive treatment with methotrexate in early rheumatoid arthritis: Aiming for remission. Computer Assisted Management in Early Rheumatoid Arthritis (CAMERA, an openlabel strategy trial). Ann Rheum Dis 2007; 66:1443-1449
-
(2007)
Ann Rheum Dis
, vol.66
, pp. 1443-1449
-
-
Verstappen, S.M.1
Jacobs, J.W.2
Van Der Veen, M.J.3
-
72
-
-
84881660129
-
Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis
-
Shea B, Swinden MV, Tanjong Ghogomu E, et al. Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis. Cochrane Database Syst Rev 2013; 5:CD000951
-
(2013)
Cochrane Database Syst Rev
, vol.5
-
-
Shea, B.1
Swinden, M.V.2
Tanjong Ghogomu, E.3
-
73
-
-
0034944211
-
Effect of folic or folinic acid supplementation on the toxicity and efficacy of methotrexate in rheumatoid arthritis: A forty-eight week, multicenter, randomized, double-blind, placebocontrolled study
-
Van Ede AE, Laan RF, Rood MJ, et al. Effect of folic or folinic acid supplementation on the toxicity and efficacy of methotrexate in rheumatoid arthritis: A forty-eight week, multicenter, randomized, double-blind, placebocontrolled study. Arthritis Rheum 2001; 44:1515-1524
-
(2001)
Arthritis Rheum
, vol.44
, pp. 1515-1524
-
-
Van Ede, A.E.1
Laan, R.F.2
Rood, M.J.3
-
74
-
-
0028593942
-
Supplementation with folic acid during methotrexate therapy for rheumatoid arthritis. A double-blind, placebo-controlled trial
-
Morgan SL, Baggott JE, Vaughn WH, et al. Supplementation with folic acid during methotrexate therapy for rheumatoid arthritis. A double-blind, placebo-controlled trial. Ann Intern Med 1994; 121:833-841
-
(1994)
Ann Intern Med
, vol.121
, pp. 833-841
-
-
Morgan, S.L.1
Baggott, J.E.2
Vaughn, W.H.3
-
75
-
-
0025037994
-
The effect of folic acid supplementation on the toxicity of low-dose methotrexate in patients with rheumatoid arthritis
-
Morgan SL, Baggott JE, Vaughn WH, et al. The effect of folic acid supplementation on the toxicity of low-dose methotrexate in patients with rheumatoid arthritis. Arthritis Rheum 1990; 33:9-18
-
(1990)
Arthritis Rheum
, vol.33
, pp. 9-18
-
-
Morgan, S.L.1
Baggott, J.E.2
Vaughn, W.H.3
-
76
-
-
0033783023
-
Do patients with rheumatoid arthritis established on methotrexate and folic acid 5mg daily need to continue folic acid supplements long term?
-
Griffith SM, Fisher J, Clarke S, et al. Do patients with rheumatoid arthritis established on methotrexate and folic acid 5mg daily need to continue folic acid supplements long term? Rheumatology (Oxford) 2000; 39:1102-1109
-
(2000)
Rheumatology (Oxford
, vol.39
, pp. 1102-1109
-
-
Griffith, S.M.1
Fisher, J.2
Clarke, S.3
-
77
-
-
60449119139
-
Effect of folic or folinic acid supplementation on methotrexateassociated safety and efficacy in inflammatory disease: A systematic review
-
Prey S, Paul C. Effect of folic or folinic acid supplementation on methotrexateassociated safety and efficacy in inflammatory disease: A systematic review. Br J Dermatol 2009; 160:622-628
-
(2009)
Br J Dermatol
, vol.160
, pp. 622-628
-
-
Prey, S.1
Paul, C.2
-
78
-
-
0028939349
-
The effect of age and renal function on the efficacy and toxicity of methotrexate in rheumatoid arthritis
-
Rheumatoid Arthritis Clinical Trial Archive Group
-
The effect of age and renal function on the efficacy and toxicity of methotrexate in rheumatoid arthritis. Rheumatoid Arthritis Clinical Trial Archive Group. J Rheumatol 1995; 22:218-223
-
(1995)
J Rheumatol
, vol.22
, pp. 218-223
-
-
-
79
-
-
0029008888
-
The relationship of preexisting lung disease to the development of methotrexate pneumonitis in patients with rheumatoid arthritis
-
Golden MR, Katz RS, Balk RA, Golden HE. The relationship of preexisting lung disease to the development of methotrexate pneumonitis in patients with rheumatoid arthritis. J Rheumatol 1995; 22:1043-1047
-
(1995)
J Rheumatol
, vol.22
, pp. 1043-1047
-
-
Golden, M.R.1
Katz, R.S.2
Balk, R.A.3
Golden, H.E.4
-
80
-
-
0029863825
-
Pulmonary function in patients receiving long-Term low-dose methotrexate
-
Cottin V, Tebib J, Massonnet B, et al. Pulmonary function in patients receiving long-Term low-dose methotrexate. Chest 1996; 109:933-938
-
(1996)
Chest
, vol.109
, pp. 933-938
-
-
Cottin, V.1
Tebib, J.2
Massonnet, B.3
-
81
-
-
0029938127
-
Pulmonary function in rheumatoid arthritis treated with low-dose methotrexate: A longitudinal study
-
Beyeler C, Jordi B, Gerber NJ, Im Hof V. Pulmonary function in rheumatoid arthritis treated with low-dose methotrexate: A longitudinal study. Br J Rheumatol 1996; 35:446-452
-
(1996)
Br J Rheumatol
, vol.35
, pp. 446-452
-
-
Beyeler, C.1
Jordi, B.2
Gerber, N.J.3
Im Hof, V.4
-
82
-
-
2342518217
-
Fulminant hepatitis in an asymptomatic chronic carrier of hepatitis B virus mutant after withdrawal of low-dose methotrexate therapy for rheumatoid arthritis
-
Hagiyama H, Kubota T, Komano Y, et al. Fulminant hepatitis in an asymptomatic chronic carrier of hepatitis B virus mutant after withdrawal of low-dose methotrexate therapy for rheumatoid arthritis. Clin Exp Rheumatol 2004; 22:375-376
-
(2004)
Clin Exp Rheumatol
, vol.22
, pp. 375-376
-
-
Hagiyama, H.1
Kubota, T.2
Komano, Y.3
-
83
-
-
0024273711
-
Methotrexate-associated hepatotoxicity: Retrospective analysis of 210 patients with rheumatoid arthritis
-
Shergy WJ, Polisson RP, Caldwell DS, et al. Methotrexate-associated hepatotoxicity: Retrospective analysis of 210 patients with rheumatoid arthritis. Am J Med 1988; 85:771-774
-
(1988)
Am J Med
, vol.85
, pp. 771-774
-
-
Shergy, W.J.1
Polisson, R.P.2
Caldwell, D.S.3
-
84
-
-
0026576192
-
Clinical liver disease in patients with rheumatoid arthritis taking methotrexate
-
Phillips CA, Cera PJ, Mangan TF, Newman ED. Clinical liver disease in patients with rheumatoid arthritis taking methotrexate. J Rheumatol 1992; 19:229-233
-
(1992)
J Rheumatol
, vol.19
, pp. 229-233
-
-
Phillips, C.A.1
Cera, P.J.2
Mangan, T.F.3
Newman, E.D.4
-
85
-
-
0027403590
-
Liver cirrhosis in rheumatoid arthritis patients treated with long-Term methotrexate
-
Minocha A, Dean HA, PittsleyRA. Liver cirrhosis in rheumatoid arthritis patients treated with long-Term methotrexate. Vet Hum Toxicol 1993; 35:45-48
-
(1993)
Vet Hum Toxicol
, vol.35
, pp. 45-48
-
-
Minocha, A.1
Dean, H.A.2
Pittsley, R.A.3
-
86
-
-
84876973836
-
Baseline laboratory test abnormalities are common in early arthritis but rarely contraindicate methotrexate: Study of three cohorts (ESPOIR, VErA, and Brittany
-
Le Boedec M, Marhadour T, Devauchelle-Pensec V, et al. Baseline laboratory test abnormalities are common in early arthritis but rarely contraindicate methotrexate: Study of three cohorts (ESPOIR, VErA, and Brittany). Semin Arthritis Rheum 2013; 42:474-481
-
(2013)
Semin Arthritis Rheum
, vol.42
, pp. 474-481
-
-
Le Boedec, M.1
Marhadour, T.2
Devauchelle-Pensec, V.3
-
87
-
-
45349090538
-
American college of rheumatology 2008 recommendations for the use of nonbiologic and biologic diseasemodifying antirheumatic drugs in rheumatoid arthritis
-
Saag KG, Teng GG, Patkar NM, et al. American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic diseasemodifying antirheumatic drugs in rheumatoid arthritis. Arthritis Rheum 2008; 59:762-784
-
(2008)
Arthritis Rheum
, vol.59
, pp. 762-784
-
-
Saag, K.G.1
Teng, G.G.2
Patkar, N.M.3
-
88
-
-
0030000725
-
Guidelines for monitoring drug therapy in rheumatoid arthritis
-
American College of Rheumatology Ad Hoc Committee on Clinical Guidelines
-
Guidelines for monitoring drug therapy in rheumatoid arthritis. American College of Rheumatology Ad Hoc Committee on Clinical Guidelines. Arthritis Rheum 1996; 39:723-731
-
(1996)
Arthritis Rheum
, vol.39
, pp. 723-731
-
-
-
89
-
-
84863871272
-
Assessing the safety of biologic agents in patients with rheumatoid arthritis
-
Rubbert-Roth A. Assessing the safety of biologic agents in patients with rheumatoid arthritis. Rheumatology (Oxford) 2012; 51 (Suppl. 5):v38-v47
-
(2012)
Rheumatology (Oxford
, vol.51
, Issue.SUPPL. 5
-
-
Rubbert-Roth, A.1
-
90
-
-
0038823915
-
Incidence and characteristics of tuberculosis in patients with autoimmune rheumatic diseases
-
Vadillo Font C, Hernandez-Garcia C, Pato E, et al. Incidence and characteristics of tuberculosis in patients with autoimmune rheumatic diseases. Rev Clin Esp 2003; 203:178-182
-
(2003)
Rev Clin Esp
, vol.203
, pp. 178-182
-
-
Vadillo Font, C.1
Hernandez-Garcia, C.2
Pato, E.3
-
91
-
-
77954425026
-
Methotrexate treatment in rheumatoid arthritis: Management in clinical remission, common infection and tuberculosis. Results from a systematic literature review
-
Bogas M, Machado P, Mourao AF, et al. Methotrexate treatment in rheumatoid arthritis: Management in clinical remission, common infection and tuberculosis. Results from a systematic literature review. Clin Rheumatol 2010; 29:629-635
-
(2010)
Clin Rheumatol
, vol.29
, pp. 629-635
-
-
Bogas, M.1
Machado, P.2
Mourao, A.F.3
-
92
-
-
84897070358
-
Adverse effects of methotrexate in three psoriatic arthritis patients
-
doi:10.1007/ s00296-012-2649-20 [Epub ahead of print]
-
Maejima H, Watarai A, Nakano T, et al. Adverse effects of methotrexate in three psoriatic arthritis patients. Rheumatol Int 2012; doi:10.1007/ s00296-012-2649-0. [Epub ahead of print]
-
(2012)
Rheumatol Int
-
-
Maejima, H.1
Watarai, A.2
Nakano, T.3
-
93
-
-
81455142061
-
Interferon gamma release assay (QuantiFERON-TB Gold In Tube) in patients of sarcoidosis from a population with high prevalence of tuberculosis infection
-
Gupta D, Kumar S, Aggarwal AN, et al. Interferon gamma release assay (QuantiFERON-TB Gold In Tube) in patients of sarcoidosis from a population with high prevalence of tuberculosis infection. Sarcoidosis Vasc Diffuse Lung Dis 2011; 28:95-101
-
(2011)
Sarcoidosis Vasc Diffuse Lung Dis
, vol.28
, pp. 95-101
-
-
Gupta, D.1
Kumar, S.2
Aggarwal, A.N.3
-
94
-
-
84881664574
-
Interferon gamma release assays in the diagnosis of latent tuberculosis infection among immunocompromised adults
-
doi:10.1164/rccm.201209- 1621CI. [Epub ahead of print]
-
Redelman-Sidi G, Sepkowitz KA. Interferon gamma release assays in the diagnosis of latent tuberculosis infection among immunocompromised adults. Am J Respir Crit Care Med 2013; doi:10.1164/rccm.201209- 1621CI. [Epub ahead of print]
-
(2013)
Am J Respir Crit Care Med
-
-
Redelman-Sidi, G.1
Sepkowitz, K.A.2
-
95
-
-
0029898079
-
Clinical pharmacokinetics of low-dose pulse methotrexate in rheumatoid arthritis
-
Bannwarth B, Pehourcq F, Schaeverbeke T, Dehais J. Clinical pharmacokinetics of low-dose pulse methotrexate in rheumatoid arthritis. Clin Pharmacokinet 1996; 30:194-210
-
(1996)
Clin Pharmacokinet
, vol.30
, pp. 194-210
-
-
Bannwarth, B.1
Pehourcq, F.2
Schaeverbeke, T.3
Dehais, J.4
-
96
-
-
70350165942
-
Sarcoidosis: Extrathoracic manifestations
-
Holmes J, Lazarus A. Sarcoidosis: Extrathoracic manifestations. Dis Mon 2009; 55:675-692
-
(2009)
Dis Mon
, vol.55
, pp. 675-692
-
-
Holmes, J.1
Lazarus, A.2
-
100
-
-
0027436223
-
Hepatic sarcoidosis. Clinicopathologic features in 100 patients
-
Devaney K, Goodman ZD, Epstein MS, et al. Hepatic sarcoidosis. Clinicopathologic features in 100 patients. Am J Surg Pathol 1993; 17:1272-1280
-
(1993)
Am J Surg Pathol
, vol.17
, pp. 1272-1280
-
-
Devaney, K.1
Goodman, Z.D.2
Epstein, M.S.3
-
101
-
-
0037429638
-
Role of liver function tests in detecting methotrexate-induced liver damage in sarcoidosis
-
Baughman RP, Koehler A, Bejarano PA, et al. Role of liver function tests in detecting methotrexate-induced liver damage in sarcoidosis. Arch Intern Med 2003; 163:615-620
-
(2003)
Arch Intern Med
, vol.163
, pp. 615-620
-
-
Baughman, R.P.1
Koehler, A.2
Bejarano, P.A.3
-
102
-
-
0242522885
-
Sarcoidosis: Assessment of disease severity using HRCT
-
Drent M, De Vries J, Lenters M, et al. Sarcoidosis: Assessment of disease severity using HRCT. Eur Radiol 2003; 13:2462-2471
-
(2003)
Eur Radiol
, vol.13
, pp. 2462-2471
-
-
Drent, M.1
De Vries, J.2
Lenters, M.3
-
103
-
-
0024504349
-
Liver histology in rheumatoid arthritis patients receiving long-Term methotrexate therapy. A prospective study with baseline and sequential biopsy samples
-
Kremer JM, Lee RG, Tolman KG. Liver histology in rheumatoid arthritis patients receiving long-Term methotrexate therapy. A prospective study with baseline and sequential biopsy samples. Arthritis Rheum 1989; 32:121-
-
(1989)
Arthritis Rheum
, vol.32
, pp. 121
-
-
Kremer, J.M.1
Lee, R.G.2
Tolman, K.G.3
-
104
-
-
0029916174
-
Significant changes in serum AST across hepatic histological biopsy grades: Prospective analysis of 3 cohorts receiving methotrexate therapy for rheumatoid arthritis
-
Kremer JM, Furst DE, Weinblatt ME, Blotner SD. Significant changes in serum AST across hepatic histological biopsy grades: Prospective analysis of 3 cohorts receiving methotrexate therapy for rheumatoid arthritis. J Rheumatol 1996; 23:459-461
-
(1996)
J Rheumatol
, vol.23
, pp. 459-461
-
-
Kremer, J.M.1
Furst, D.E.2
Weinblatt, M.E.3
Blotner, S.D.4
-
105
-
-
0022252104
-
Methotrexate and the liver
-
Tolman KG, Clegg DO, Lee RG, Ward Jr. Methotrexate and the liver. J Rheumatol Suppl 1985; 12 (Suppl. 12):29-34
-
(1985)
J RheumatolSUPPL
, vol.12
, Issue.SUPPL. 12
, pp. 29-34
-
-
Tolman, K.G.1
Clegg, D.O.2
Lee, R.G.3
Ward, J.R.4
-
106
-
-
0025345226
-
Liver histology in patients receiving low dose pulse methotrexate for the treatment of rheumatoid arthritis
-
Willkens RF, Leonard PA, Clegg DO, et al. Liver histology in patients receiving low dose pulse methotrexate for the treatment of rheumatoid arthritis. Ann Rheum Dis 1990; 49:591-593
-
(1990)
Ann Rheum Dis
, vol.49
, pp. 591-593
-
-
Willkens, R.F.1
Leonard, P.A.2
Clegg, D.O.3
-
107
-
-
0022510811
-
The safety and efficacy of the use of methotrexate in longterm therapy for rheumatoid arthritis
-
Kremer JM, Lee JK. The safety and efficacy of the use of methotrexate in longterm therapy for rheumatoid arthritis. Arthritis Rheum 1986; 29:822-831
-
(1986)
Arthritis Rheum
, vol.29
, pp. 822-831
-
-
Kremer, J.M.1
Lee, J.K.2
-
108
-
-
0026315404
-
Methotrexate and histologic hepatic abnormalities: A meta-analysis
-
Whiting-O'Keefe QE, Fye KH, Sack KD. Methotrexate and histologic hepatic abnormalities: A meta-analysis. Am J Med 1991; 90:711-716
-
(1991)
Am J Med
, vol.90
, pp. 711-716
-
-
Whiting-O'Keefe, Q.E.1
Fye, K.H.2
Sack, K.D.3
-
109
-
-
33745819196
-
Methotrexate therapy for rheumatoid arthritis: Clinical practice guidelines based on published evidence and expert opinion
-
Pavy S, Constantin A, Pham T, et al. Methotrexate therapy for rheumatoid arthritis: Clinical practice guidelines based on published evidence and expert opinion. Joint Bone Spine 2006; 73:388-395
-
(2006)
Joint Bone Spine
, vol.73
, pp. 388-395
-
-
Pavy, S.1
Constantin, A.2
Pham, T.3
-
110
-
-
33644681620
-
Splitting high-dose oral methotrexate improves bioavailability: A pharmacokinetic study in patients with rheumatoid arthritis
-
Hoekstra M, Haagsma C, Neef C, et al. Splitting high-dose oral methotrexate improves bioavailability: A pharmacokinetic study in patients with rheumatoid arthritis. J Rheumatol 2006; 33:481-485
-
(2006)
J Rheumatol
, vol.33
, pp. 481-485
-
-
Hoekstra, M.1
Haagsma, C.2
Neef, C.3
-
112
-
-
0035997498
-
Relapse of rheumatoid arthritis after substitution of oral for parenteral administration of methotrexate
-
Rozin A, Schapira D, Balbir-Gurman A, et al. Relapse of rheumatoid arthritis after substitution of oral for parenteral administration of methotrexate. Ann Rheum Dis 2002; 61:756-757
-
(2002)
Ann Rheum Dis
, vol.61
, pp. 756-757
-
-
Rozin, A.1
Schapira, D.2
Balbir-Gurman, A.3
-
113
-
-
0027744086
-
A comparison of low dose methotrexate bioavailability: Oral solution, oral tablet, subcutaneous and intramuscular dosing
-
Jundt JW, Browne BA, Fiocco GP, et al. A comparison of low dose methotrexate bioavailability: Oral solution, oral tablet, subcutaneous and intramuscular dosing. J Rheumatol 1993; 20:1845-1849
-
(1993)
J Rheumatol
, vol.20
, pp. 1845-1849
-
-
Jundt, J.W.1
Browne, B.A.2
Fiocco, G.P.3
-
114
-
-
1842425908
-
Bioavailability of higher dose methotrexate comparing oral and subcutaneous administration in patients with rheumatoid arthritis
-
Hoekstra M, Haagsma C, Neef C, et al. Bioavailability of higher dose methotrexate comparing oral and subcutaneous administration in patients with rheumatoid arthritis. J Rheumatol 2004; 31:645-648
-
(2004)
J Rheumatol
, vol.31
, pp. 645-648
-
-
Hoekstra, M.1
Haagsma, C.2
Neef, C.3
-
115
-
-
1042278744
-
Dose escalation of parenteral methotrexate in active rheumatoid arthritis that has been unresponsive to conventional doses of methotrexate: A randomized, controlled trial
-
Lambert CM, Sandhu S, Lochhead A, et al. Dose escalation of parenteral methotrexate in active rheumatoid arthritis that has been unresponsive to conventional doses of methotrexate: A randomized, controlled trial. Arthritis Rheum 2004; 50:364-371
-
(2004)
Arthritis Rheum
, vol.50
, pp. 364-371
-
-
Lambert, C.M.1
Sandhu, S.2
Lochhead, A.3
-
116
-
-
0141727725
-
Parenteral methotrexate should be given before biological therapy
-
Bingham SJ, Buch MH, Lindsay S, et al. Parenteral methotrexate should be given before biological therapy. Rheumatology (Oxford) 2003; 42:1009-1010
-
(2003)
Rheumatology (Oxford
, vol.42
, pp. 1009-1010
-
-
Bingham, S.J.1
Buch, M.H.2
Lindsay, S.3
-
118
-
-
80355138040
-
Effectiveness and safety of leflunomide for pulmonary and extrapulmonary sarcoidosis
-
Sahoo DH, Bandyopadhyay D, Xu M, et al. Effectiveness and safety of leflunomide for pulmonary and extrapulmonary sarcoidosis. Eur Respir J 2011; 38:1145-1150
-
(2011)
Eur Respir J
, vol.38
, pp. 1145-1150
-
-
Sahoo, D.H.1
Bandyopadhyay, D.2
Xu, M.3
-
119
-
-
0037029418
-
Methotrexate and mortality in patients with rheumatoid arthritis: A prospective study
-
Choi HK, Hernan MA, Seeger JD, et al. Methotrexate and mortality in patients with rheumatoid arthritis: A prospective study. Lancet 2002; 359:1173-1177
-
(2002)
Lancet
, vol.359
, pp. 1173-1177
-
-
Choi, H.K.1
Hernan, M.A.2
Seeger, J.D.3
-
120
-
-
13244295795
-
Long term safety of methotrexate in routine clinical care: Discontinuation is unusual and rarely the result of laboratory abnormalities
-
Yazici Y, Sokka T, Kautiainen H, et al. Long term safety of methotrexate in routine clinical care: Discontinuation is unusual and rarely the result of laboratory abnormalities. Ann Rheum Dis 2005; 64:207-211
-
(2005)
Ann Rheum Dis
, vol.64
, pp. 207-211
-
-
Yazici, Y.1
Sokka, T.2
Kautiainen, H.3
-
121
-
-
67549107120
-
Long-Term safety of methotrexate monotherapy in patients with rheumatoid arthritis: A systematic literature research
-
Salliot C, van der Heijde D. Long-Term safety of methotrexate monotherapy in patients with rheumatoid arthritis: A systematic literature research. Ann Rheum Dis 2009; 68:1100-1104
-
(2009)
Ann Rheum Dis
, vol.68
, pp. 1100-1104
-
-
Salliot, C.1
Van Der Heijde, D.2
-
122
-
-
0036745010
-
Predictors of infection in rheumatoid arthritis
-
Doran MF, Crowson CS, PondGR, et al. Predictors of infection in rheumatoid arthritis. Arthritis Rheum 2002; 46:2294-2300
-
(2002)
Arthritis Rheum
, vol.46
, pp. 2294-2300
-
-
Doran, M.F.1
Crowson, C.S.2
Pond, G.R.3
-
123
-
-
2642554059
-
Lymphoma in rheumatoid arthritis: The effect of methotrexate and antitumor necrosis factor therapy in 18,572 patients
-
Wolfe F, Michaud K. Lymphoma in rheumatoid arthritis: The effect of methotrexate and antitumor necrosis factor therapy in 18,572 patients. Arthritis Rheum 2004; 50:1740-1751
-
(2004)
Arthritis Rheum
, vol.50
, pp. 1740-1751
-
-
Wolfe, F.1
Michaud, K.2
-
124
-
-
0036624739
-
Lymphomas in rheumatoid arthritis patients treated with methotrexate: A 3-year prospective study in France
-
Mariette X, Cazals-Hatem D, Warszawki J, et al. Lymphomas in rheumatoid arthritis patients treated with methotrexate: A 3-year prospective study in France. Blood 2002; 99:3909-3915
-
(2002)
Blood
, vol.99
, pp. 3909-3915
-
-
Mariette, X.1
Cazals-Hatem, D.2
Warszawki, J.3
-
125
-
-
34250201534
-
Therapy with immunosuppressive drugs and biological agents and use of contraception in patients with rheumatic disease
-
Ostensen M, von Esebeck M, Villiger PM. Therapy with immunosuppressive drugs and biological agents and use of contraception in patients with rheumatic disease. J Rheumatol 2007; 34:1266-1269
-
(2007)
J Rheumatol
, vol.34
, pp. 1266-1269
-
-
Ostensen, M.1
Von Esebeck, M.2
Villiger, P.M.3
-
126
-
-
0033848448
-
Low dose weekly methotrexate in early pregnancy. A case series and review of the literature
-
Ostensen M, Hartmann H, Salvesen K. Low dose weekly methotrexate in early pregnancy. A case series and review of the literature. J Rheumatol 2000; 27:1872-1875
-
(2000)
J Rheumatol
, vol.27
, pp. 1872-1875
-
-
Ostensen, M.1
Hartmann, H.2
Salvesen, K.3
-
127
-
-
10044253361
-
Low dose methotrexate in the first trimester of pregnancy: Results of a French collaborative study
-
Lewden B, Vial T, Elefant E, et al. Low dose methotrexate in the first trimester of pregnancy: Results of a French collaborative study. J Rheumatol 2004; 31:2360-2365
-
(2004)
J Rheumatol
, vol.31
, pp. 2360-2365
-
-
Lewden, B.1
Vial, T.2
Elefant, E.3
-
128
-
-
0025315423
-
Outcome of firsttrimester exposure to low-dose methotrexate in eight patients with rheumatic disease
-
Kozlowski RD, Steinbrunner JV, MacKenzie AH, et al. Outcome of firsttrimester exposure to low-dose methotrexate in eight patients with rheumatic disease. Am J Med 1990; 88:589-592
-
(1990)
Am J Med
, vol.88
, pp. 589-592
-
-
Kozlowski, R.D.1
Steinbrunner, J.V.2
MacKenzie, A.H.3
-
129
-
-
0028217035
-
Methotrexate exposure prior to and during pregnancy
-
Donnenfeld AE, Pastuszak A, Noah JS, et al. Methotrexate exposure prior to and during pregnancy. Teratology 1994; 49:79-81
-
(1994)
Teratology
, vol.49
, pp. 79-81
-
-
Donnenfeld, A.E.1
Pastuszak, A.2
Noah, J.S.3
-
130
-
-
0037309462
-
The use of disease modifying antirheumatic drugs in women with rheumatoid arthritis of childbearing age: A survey of practice patterns and pregnancy outcomes
-
Chakravarty EF, Sanchez-Yamamoto D, Bush TM. The use of disease modifying antirheumatic drugs in women with rheumatoid arthritis of childbearing age: A survey of practice patterns and pregnancy outcomes. J Rheumatol 2003; 30:241-246
-
(2003)
J Rheumatol
, vol.30
, pp. 241-246
-
-
Chakravarty, E.F.1
Sanchez-Yamamoto, D.2
Bush, T.M.3
|